Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

N9741: Oxaliplatin (OXAL) or CPT-11 + 5-Fluorouracil (5FU)/Leucovorin (LV) or Oxal + CPT-11 in advanced colorectal cancer (CRC). Initial toxicity and response data from a GI intergroup study

Goldberg RM, Morton R, Sargent DJ, Fuchs C, Ramanathan R, Williamson S, Findlay B. N9741: Oxaliplatin (OXAL) or CPT-11 + 5-Fluorouracil (5FU)/Leucovorin (LV) or Oxal + CPT-11 in advanced colorectal cancer (CRC). Initial toxicity and response data from a GI intergroup study. Journal of Clinical Oncology, ASCO Annual Meeting Proceedings. 2002.


© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.